Serina Therapeutics (AL), Inc.
Serina Therapeutics (AL), Inc. is a registered legal entity registered in United States under 000-249-619, and its current status with Alabama Secretary of State is active. The company was incorporated on 20 October 2006 and lists its registered address as United States. 5 shareholders are on record for Serina Therapeutics (AL), Inc., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Alabama Secretary of State and was last updated on 18 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Shareholders of Serina Therapeutics (AL), Inc.
Five shareholders are currently on record for Serina Therapeutics (AL), Inc., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund, holding 19% — the largest recorded stake — followed by VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund at 5%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Data availability
The register reports 7 shareholders in total, though only the top 5 by holding are shown in this view.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 19% | Alabama Secretary of State | |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 5% | Alabama Secretary of State | |
| Northern Funds-SMALL CAP CORE FUND | 1.1% | Alabama Secretary of State | |
| Northern Funds-SMALL CAP CORE FUND | 1.1% | Alabama Secretary of State | |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 0.1% | Alabama Secretary of State |
Officers
16
Directors and officers of Serina Therapeutics (AL), Inc.
The Co-founder, Director Emeritus & Chair Of Scientific Advisory Board of Serina Therapeutics (AL), Inc. currently on record is J. Milton Harris Ph.d.; 16 officers are currently on record for Serina Therapeutics (AL), Inc., filed with Alabama Secretary of State. Management authority at Serina Therapeutics (AL), Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Group structure of Serina Therapeutics (AL), Inc.
Serina Therapeutics (AL), Inc. sits 1 level below its ultimate parent, Serina Therapeutics, Inc., registered in United States. The full chain up to Serina Therapeutics, Inc. is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by Serina Therapeutics (AL), Inc.'s own shareholder record.
Serina Therapeutics, Inc.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Serina Therapeutics (AL), Inc.?
Five shareholders are currently on record for Serina Therapeutics (AL), Inc., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund, holding 19% — the largest recorded stake — followed by VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund at 5%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Serina Therapeutics (AL), Inc.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Serina Therapeutics (AL), Inc. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Serina Therapeutics (AL), Inc. have on record?
5 shareholders are shown on record for Serina Therapeutics (AL), Inc.. The register reports 7 in total; only the top 5 by holding are shown here.
What is Serina Therapeutics (AL), Inc.'s company registration number?
Serina Therapeutics (AL), Inc.'s registration number is 000-249-619, filed with Alabama Secretary of State in United States. Its current status on the register is active.
Is Serina Therapeutics (AL), Inc. still an active company?
Serina Therapeutics (AL), Inc.'s status on Alabama Secretary of State is listed as active.
When was Serina Therapeutics (AL), Inc. incorporated?
Serina Therapeutics (AL), Inc. was incorporated on 20 October 2006, according to Alabama Secretary of State.
What is Serina Therapeutics (AL), Inc.'s registered address?
The registered address on file for Serina Therapeutics (AL), Inc. is United States.
Who are the officers/directors of Serina Therapeutics (AL), Inc.?
The Co-founder, Director Emeritus & Chair Of Scientific Advisory Board of Serina Therapeutics (AL), Inc. currently on record is J. Milton Harris Ph.d.; 16 officers are currently on record for Serina Therapeutics (AL), Inc., filed with Alabama Secretary of State. Management authority at Serina Therapeutics (AL), Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Serina Therapeutics (AL), Inc. have a parent company or subsidiaries?
Serina Therapeutics (AL), Inc. sits 1 level below its ultimate parent, Serina Therapeutics, Inc., registered in United States.
Can Zavia monitor changes to Serina Therapeutics (AL), Inc.'s ownership over time?
This profile reflects a point-in-time snapshot from Alabama Secretary of State. Zavia's monitoring API can track changes to Serina Therapeutics (AL), Inc.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Serina Therapeutics (AL), Inc.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like Serina Therapeutics (AL), Inc.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Alabama Secretary of State and was last synced on 18 September 2026.